☰

Jean Addington - Publications

Affiliations: 
University of Calgary, Calgary, Alberta, Canada 
Area:
Clinical Psychology
Tree Info Grants Similar researchers PubMed Report error

327 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Nogovitsyn N, Ballester P, Lasby M, Dunlop K, Ceniti AK, Squires S, Rowe J, Ho K, Suh J, Hassel S, Souza R, Casseb RF, Harris JK, Zamyadi M, Arnott SR, ... ... Addington J, et al. An empirical analysis of structural neuroimaging profiles in a staging model of depression. Journal of Affective Disorders. PMID 38290583 DOI: 10.1016/j.jad.2024.01.246  0.523
2023 Jalali S, Liu L, Wang J, Kennedy SH, MacQueen G, Lebel C, Goldstein BL, Bray S, Addington J. Factors Associated with Transition to Serious Mental Illness. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437231195959. PMID 37606525 DOI: 10.1177/07067437231195959  0.636
2022 Barbato M, Liu L, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone W, Tsuang MT, Walker EF, Woods SW, Cannon TD, ... Addington J, et al. Migrant status, clinical symptoms and functional outcome in youth at clinical high risk for psychosis: findings from the NAPLS-3 study. Social Psychiatry and Psychiatric Epidemiology. PMID 36348056 DOI: 10.1007/s00127-022-02383-y  0.31
2022 Metzak PD, Shakeel MK, Long X, Lasby M, Souza R, Bray S, Goldstein BI, MacQueen G, Wang J, Kennedy SH, Addington J, Lebel C. Brain connectomes in youth at risk for serious mental illness: an exploratory analysis. Bmc Psychiatry. 22: 611. PMID 36109720 DOI: 10.1186/s12888-022-04118-4  0.603
2022 Santesteban-Echarri O, Sandel D, Liu L, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Tsuang MT, Walker EF, ... ... Addington J, et al. Family history of psychosis in youth at clinical high risk: A replication study. Psychiatry Research. 311: 114480. PMID 35245743 DOI: 10.1016/j.psychres.2022.114480  0.327
2022 Nogovitsyn N, Metzak PD, Casseb RF, Souza R, Harris JK, Prati LM, Zamyadi M, Bray SL, Lebel C, Hassel S, Strother S, Goldstein BI, Wang J, Kennedy SH, MacQueen GM, ... Addington J, et al. Cerebello-limbic functional connectivity patterns in youth at clinical high risk for psychosis. Schizophrenia Research. 240: 220-227. PMID 35074702 DOI: 10.1016/j.schres.2021.12.041  0.801
2021 Shakeel MK, Hassel S, Davis AD, Metzak PD, MacQueen GM, Arnott SR, Bray S, Frey BN, Goldstein BI, Hall GB, Harris J, Lam RW, MacIntosh BJ, Milev R, Mueller DJ, ... ... Addington J, et al. White matter microstructure in youth at risk for serious mental illness: A comparative analysis. Psychiatry Research. Neuroimaging. 312: 111289. PMID 33910139 DOI: 10.1016/j.pscychresns.2021.111289  0.691
2021 Farris MS, Braun A, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Addington J. Longitudinal Trends in Medication Treatment for Youth At-Risk for Serious Mental Illness. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743720988450. PMID 33464130 DOI: 10.1177/0706743720988450  0.603
2020 Metzak PD, Addington J, Hassel S, Goldstein BI, MacIntosh BJ, Lebel C, Wang JL, Kennedy SH, MacQueen GM, Bray S. Functional imaging in youth at risk for transdiagnostic serious mental illness: Initial results from the PROCAN study. Early Intervention in Psychiatry. PMID 33295151 DOI: 10.1111/eip.13078  0.595
2020 Addington J, Liu L, Farris MS, Goldstein BI, Wang JL, Kennedy SH, Bray S, Lebel C, MacQueen G. Clinical staging for youth at-risk for serious mental illness: A longitudinal perspective. Early Intervention in Psychiatry. PMID 33037783 DOI: 10.1111/eip.13062  0.62
2020 Corbett S, Metzak P, MacQueen G, Farris M, Addington J. Aerobic exercise and hippocampal change in youth at risk of serious mental illness. Psychiatry Research. Neuroimaging. 305: 111199. PMID 33035755 DOI: 10.1016/j.pscychresns.2020.111199  0.479
2020 Cadenhead KS, Duncan E, Addington J, Bearden C, Cannon TD, Cornblatt BA, Mathalon D, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Bauchman P, Belger A, et al. Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle Paradigm. Frontiers in Psychiatry. 11: 833. PMID 33005152 DOI: 10.3389/Fpsyt.2020.00833  0.417
2020 Calkins ME, Woods SW, Bearden CE, Liu L, Moore TM, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Mathalon DH, Keshavan M, ... ... Addington J, et al. Concordance and factor structure of subthreshold positive symptoms in youth at clinical high risk for psychosis. Schizophrenia Research. PMID 32943313 DOI: 10.1016/J.Schres.2020.08.014  0.402
2020 Nogovitsyn N, Addington J, Souza R, Placsko TJ, Stowkowy J, Wang J, Goldstein BI, Bray S, Lebel C, Taylor VH, Kennedy SH, MacQueen G. Childhood trauma and amygdala nuclei volumes in youth at risk for mental illness. Psychological Medicine. 1-8. PMID 32940197 DOI: 10.1017/S0033291720003177  0.789
2020 LoPilato AM, Zhang Y, Pike M, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman L, Perkins DO, Tsuang MT, Woods SW, Walker EF. Associations between childhood adversity, cognitive schemas and attenuated psychotic symptoms. Early Intervention in Psychiatry. PMID 32770658 DOI: 10.1111/Eip.13017  0.348
2020 Metzak PD, Devoe DJ, Iwaschuk A, Braun A, Addington J. Brain changes associated with negative symptoms in clinical high risk for psychosis: A systematic review. Neuroscience and Biobehavioral Reviews. 118: 367-383. PMID 32768487 DOI: 10.1016/J.Neubiorev.2020.07.041  0.377
2020 Shakeel MK, MacQueen G, Addington J, Metzak PD, Georgopoulos G, Bray S, Goldstein BI, MacIntosh BJ, Wang J, Kennedy SH, Lebel C. White Matter Connectivity in Youth at Risk for Serious Mental Illness: A Longitudinal Analysis. Psychiatry Research. Neuroimaging. 302: 111106. PMID 32505905 DOI: 10.1016/J.Pscychresns.2020.111106  0.636
2020 Farris MS, Shakeel MK, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Substance use in youth at-risk for serious mental illness. Early Intervention in Psychiatry. PMID 32500614 DOI: 10.1111/Eip.12995  0.655
2020 Kozloff N, Foussias G, Durbin J, Sockalingam S, Addington J, Addington D, Ampofo A, Anderson KK, Barwick M, Bromley S, Cunningham JEA, Dahrouge S, Duda L, Ford C, Gallagher S, et al. Early Psychosis Intervention-Spreading Evidence-based Treatment (EPI-SET): protocol for an effectiveness-implementation study of a structured model of care for psychosis in youth and emerging adults. Bmj Open. 10: e034280. PMID 32499262 DOI: 10.1136/Bmjopen-2019-034280  0.302
2020 Corbett S, Farris MS, MacQueen G, Addington J. Pilot aerobic exercise intervention for youth at-risk for serious mental illness. Early Intervention in Psychiatry. PMID 32452641 DOI: 10.1111/Eip.12977  0.509
2020 Woods SW, Bearden CE, Sabb FW, Stone WS, Torous J, Cornblatt BA, Perkins DO, Cadenhead KS, Addington J, Powers AR, Mathalon DH, Calkins ME, Wolf DH, Corcoran CM, Horton LE, et al. Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit. Schizophrenia Research. PMID 32402605 DOI: 10.1016/J.Schres.2020.04.020  0.344
2020 Devoe DJ, Lu L, Cannon TD, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Walker EF, Mathalon DH, Bearden CE, Addington J. Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study. Schizophrenia Research. PMID 32362460 DOI: 10.1016/J.Schres.2020.04.004  0.419
2020 Addington J, Liu L, Brummitt K, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone W, Tsuang MT, Walker EF, Woods SW, et al. North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description. Schizophrenia Research. PMID 32317224 DOI: 10.1016/J.Schres.2020.04.010  0.333
2020 Santesteban-Echarri O, Tang J, Shakeel MK, Fernandes J, Addington J. A mobile-based app to monitor social functioning among youth at-risk for psychosis: Single-arm feasibility and acceptability study. General Hospital Psychiatry. PMID 32317101 DOI: 10.1016/J.Genhosppsych.2020.04.003  0.334
2020 Roach BJ, Hamilton HK, Bachman P, Belger A, Carrión RE, Duncan E, Johannesen J, Kenney JG, Light G, Niznikiewicz M, Addington J, Bearden CE, Owens EM, Cadenhead KS, Cannon TD, et al. Stability of mismatch negativity event-related potentials in a multisite study. International Journal of Methods in Psychiatric Research. e1819. PMID 32232944 DOI: 10.1002/Mpr.1819  0.307
2020 Cullen AE, Addington J, Bearden CE, Stone WS, Seidman LJ, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Walker EF. Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort. Psychoneuroendocrinology. 115: 104649. PMID 32197198 DOI: 10.1016/J.Psyneuen.2020.104649  0.336
2020 Nogovitsyn N, Souza R, Muller M, Srajer A, Metzak PD, Hassel S, Ismail Z, Protzner A, Bray SL, Lebel C, MacIntosh BJ, Goldstein BI, Wang J, Kennedy SH, Addington J, et al. Aberrant limbic brain structures in young individuals at risk for mental illness. Psychiatry and Clinical Neurosciences. PMID 32003517 DOI: 10.1111/Pcn.12985  0.8
2020 Velikonja T, Velthorst E, Zinberg J, Cannon TD, Cornblatt BA, Perkins DO, Cadenhead KS, Tsuang MT, Addington J, Woods SW, McGlashan T, Mathalon DH, Stone W, Keshavan M, Seidman L, et al. Childhood trauma and cognitive functioning in individuals at clinical high risk (CHR) for psychosis. Development and Psychopathology. 1-12. PMID 31959269 DOI: 10.1017/S095457941900155X  0.377
2020 Santesteban-Echarri O, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Personality and risk for serious mental illness. Early Intervention in Psychiatry. PMID 31910491 DOI: 10.1111/Eip.12921  0.661
2020 Stowkowy J, Goldstein BI, MacQueen G, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Trauma in Youth At-Risk for Serious Mental Illness. The Journal of Nervous and Mental Disease. 208: 70-76. PMID 31834192 DOI: 10.1097/Nmd.0000000000001069  0.654
2020 Santesteban-Echarri O, Tang J, Fernandes J, Addington J. S106. Monitoring Social Functioning Through A Mobile-Based Application For Youth At-Risk Of Psychosis: 2-Month Feasibility Study Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa031.172  0.333
2020 Santesteban-Echarri O, Kim GH, Haffey P, Tang J, Addington J. M100. Looseleaf: Developing A Mobile-Based Application To Monitor Daily Cannabis Usage In Youth At Clinical High-Risk Of Psychosis: App Development And Usability Testing Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa030.412  0.329
2020 Worthington M, Addington J, Bearden C, Cadenhead K, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Seidman L, Tsuang M, Walker E, Woods S, Cannon T. T116. PREDICTION OF REMISSION IN NON-CONVERTING INDIVIDUALS AT CLINICAL HIGH RISK FOR PSYCHOSIS Schizophrenia Bulletin. 46: S274-S275. DOI: 10.1093/Schbul/Sbaa029.676  0.363
2020 Hamilton H, Roach B, Bachman P, Belger A, Carrion R, Johannesen J, Light G, Niznikiewicz M, Addington J, Bearden C, Cadenhead K, Cornblatt B, McGlashan T, Perkins D, Seidman L, et al. O10.2. DEFICIENT VISUAL ODDBALL STIMULUS PROCESSING PREDICTS PSYCHOSIS ONSET: RESULTS FROM THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY Schizophrenia Bulletin. 46: S24-S25. DOI: 10.1093/Schbul/Sbaa028.056  0.325
2020 Di Biase M, Cetin Karayumak S, Zalesky A, Kubicki M, Rathi Y, Lyons MG, Bouix S, Billah T, Higger M, Anticevic A, Addington J, Bearden CE, Cornblatt BA, Keshavan MS, Mathalon DH, et al. O5.6. ADVANCED DIFFUSION IMAGING IN PSYCHOSIS RISK: A CROSS-SECTIONAL AND LONGITUDINAL STUDY OF WHITE MATTER DEVELOPMENT Schizophrenia Bulletin. 46: S13-S13. DOI: 10.1093/Schbul/Sbaa028.029  0.347
2019 Yoviene Sykes LA, Ferrara M, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Mathalon DH, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH, Woodberry KA, Powers AR, et al. Predictive validity of conversion from the clinical high risk syndrome to frank psychosis. Schizophrenia Research. PMID 31864837 DOI: 10.1016/J.Schres.2019.12.002  0.379
2019 Powers AR, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH, Woods SW. Duration of the psychosis prodrome. Schizophrenia Research. PMID 31806523 DOI: 10.1016/J.Schres.2019.10.051  0.331
2019 Farris MS, Shakeel MK, Addington J. Cannabis use in individuals at clinical high-risk for psychosis: a comprehensive review. Social Psychiatry and Psychiatric Epidemiology. PMID 31796983 DOI: 10.1007/s00127-019-01810-x  0.318
2019 Stowkowy J, Brummitt K, Bonneville D, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, MacQueen G, Addington J. Sleep disturbances in youth at-risk for serious mental illness. Early Intervention in Psychiatry. PMID 31724327 DOI: 10.1111/Eip.12898  0.613
2019 Perkins DO, Olde Loohuis L, Barbee J, Ford J, Jeffries CD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang M, Walker EF, et al. Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk. The American Journal of Psychiatry. appiajp201918060721. PMID 31711302 DOI: 10.1176/Appi.Ajp.2019.18060721  0.371
2019 Nogovitsyn N, Muller M, Souza R, Hassel S, Arnott SR, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, Ismail Z, Downar J, Parikh SV, Soares CN, Addington JM, et al. Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31610545 DOI: 10.1038/S41386-019-0542-1  0.769
2019 Allswede DM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan T, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon TD. Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains. The American Journal of Psychiatry. appiajp201918111290. PMID 31509005 DOI: 10.1176/Appi.Ajp.2019.18111290  0.405
2019 Romanowska S, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Social and role functioning in youth at risk of serious mental illness. Early Intervention in Psychiatry. PMID 31502422 DOI: 10.1111/Eip.12872  0.664
2019 Farris MS, Devoe DJ, Addington J. Attrition rates in trials for adolescents and young adults at clinical high-risk for psychosis: A systematic review and meta-analysis. Early Intervention in Psychiatry. PMID 31422583 DOI: 10.1111/Eip.12864  0.354
2019 Addington J, Devoe DJ, Santesteban-Echarri O. Multidisciplinary Treatment for Individuals at Clinical High Risk of Developing Psychosis. Current Treatment Options in Psychiatry. 6: 1-16. PMID 31403023 DOI: 10.1007/S40501-019-0164-6  0.387
2019 Hamilton HK, Roach BJ, Bachman PM, Belger A, Carrion RE, Duncan E, Johannesen JK, Light GA, Niznikiewicz MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, et al. Association Between P300 Responses to Auditory Oddball Stimuli and Clinical Outcomes in the Psychosis Risk Syndrome. Jama Psychiatry. PMID 31389974 DOI: 10.1001/Jamapsychiatry.2019.2135  0.405
2019 Goines KB, LoPilato AM, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Walker EF. Sleep problems and attenuated psychotic symptoms in youth at clinical high-risk for psychosis. Psychiatry Research. 112492. PMID 31387769 DOI: 10.1016/J.Psychres.2019.112492  0.313
2019 Addington J, Shakeel MK, Braun A, Bonneville D, Stowkowy J. Metacognition in youth at-risk for psychosis. Schizophrenia Research. PMID 31296413 DOI: 10.1016/J.Schres.2019.07.005  0.384
2019 Malda A, Boonstra N, Barf H, de Jong S, Aleman A, Addington J, Pruessner M, Nieman D, de Haan L, Morrison A, Riecher-Rössler A, Studerus E, Ruhrmann S, Schultze-Lutter F, An SK, et al. Individualized Prediction of Transition to Psychosis in 1,676 Individuals at Clinical High Risk: Development and Validation of a Multivariable Prediction Model Based on Individual Patient Data Meta-Analysis. Frontiers in Psychiatry. 10: 345. PMID 31178767 DOI: 10.3389/Fpsyt.2019.00345  0.386
2019 Chung Y, Allswede D, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, McEwen S, van Erp TGM, et al. Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort. Neuroimage. Clinical. 23: 101862. PMID 31150956 DOI: 10.1016/J.Nicl.2019.101862  0.413
2019 Nogovitsyn N, Souza R, Muller M, Srajer A, Hassel S, Arnott SR, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, Ismail Z, Bray SL, Lebel C, Addington JM, et al. Testing a deep convolutional neural network for automated hippocampus segmentation in a longitudinal sample of healthy participants. Neuroimage. PMID 31075395 DOI: 10.1016/J.Neuroimage.2019.05.017  0.756
2019 Addington J, Farris M, Stowkowy J, Santesteban-Echarri O, Metzak P, Kalathil MS. Predictors of Transition to Psychosis in Individuals at Clinical High Risk. Current Psychiatry Reports. 21: 39. PMID 31037392 DOI: 10.1007/S11920-019-1027-Y  0.405
2019 Shakeel MK, Lu L, Woods SW, Perkins DO, Addington J. Neurocognitive predictors of metacognition in individuals at clinical high risk for psychosis. Behavioural and Cognitive Psychotherapy. 1-5. PMID 30982487 DOI: 10.1017/S1352465819000328  0.419
2019 Foss-Feig JH, Velthorst E, Smith L, Reichenberg A, Addington J, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Keshavan M, Tsuang MT, Walker EF, et al. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk For Psychosis Services. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 30797038 DOI: 10.1016/J.Jaac.2018.09.446  0.365
2019 LoPilato AM, Goines K, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman L, Perkins DO, Tsuang MT, Woods SW, Walker EF. Impact of childhood adversity on corticolimbic volumes in youth at clinical high-risk for psychosis. Schizophrenia Research. PMID 30745068 DOI: 10.1016/J.Schres.2019.01.048  0.401
2019 Chung Y, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, McEwen S, van Erp TGM, Cannon TD, et al. Adding a neuroanatomical biomarker to an individualized risk calculator for psychosis: A proof-of-concept study. Schizophrenia Research. PMID 30745066 DOI: 10.1016/J.Schres.2019.01.026  0.321
2019 Addington J, Liu L, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Stowkowy J, MacQueen G. Clinical staging for youth at-risk for serious mental illness. Early Intervention in Psychiatry. PMID 30672153 DOI: 10.1111/Eip.12786  0.645
2019 Devoe D, Liu L, Cadenhead K, Cannon T, Cornblatt B, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods S, Bearden C, Mathalon D, Addington J. S21. THE IMPACT OF PERSISTENT NEGATIVE SYMPTOMS ON FUNCTIONING AND DEFEATIST BELIEFS IN YOUTH AT CLINICAL HIGH RISK FOR PSYCHOSIS Schizophrenia Bulletin. 45: S313-S313. DOI: 10.1093/Schbul/Sbz020.566  0.407
2019 Devoe D, Addington J. T29. TREATMENT AND GLOBAL FUNCTIONING IN YOUTH AT CLINICAL HIGH RISK FOR PSYCHOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS Schizophrenia Bulletin. 45: S214-S214. DOI: 10.1093/Schbul/Sbz019.309  0.341
2019 Martin AS, Johannesen J, Roach B, Hamilton H, Bachman P, Belger A, Carrión R, Duncan E, Light G, Niznikiewicz M, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, et al. S190. Does Cannabis Use Interact With Neurophysiological Vulnerability in the Early Expression of Psychosis and Conversion Status in Clinical High-Risk (CHR) Individuals? Biological Psychiatry. 85: S370-S371. DOI: 10.1016/J.Biopsych.2019.03.941  0.371
2019 Nogovitsyn N, Srajer A, Muller M, Metzak P, Hassel S, Souza R, Bray S, Lebel C, Goldstein B, Kennedy S, Ismail Z, Protzner A, Addington J, MacQueen G. F130. Subfield-Specific Hippocampal Volumes in Youth at Risk for Mental Illness Biological Psychiatry. 85: S263-S264. DOI: 10.1016/J.Biopsych.2019.03.667  0.786
2019 Desjardins C, Nogovitsyn N, Souza R, Hassel S, Arnott S, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, Bray S, Lebel C, Addington J, Milev R, Harkness K, et al. F113. Hippocampal Subfield-Specific Sex Differences in Patients With Major Depressive Disorder Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.650  0.759
2019 Ramyead A, Roach B, Hamilton H, Addington J, Bachman P, Bearden C, Belger A, Cadenhead K, Cannon T, Carrion R, Cornblatt B, Duncan E, Johannesen J, Light G, McGlashan T, et al. O33. EEG Alpha Event-Related Desynchronization Deficits Predict Conversion to Psychosis in Individuals With the Psychosis Risk Syndrome Biological Psychiatry. 85: S119. DOI: 10.1016/J.Biopsych.2019.03.298  0.304
2018 Goldsmith DR, Haroon E, Miller AH, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Seidman L, Tsuang M, Woods SW, Walker EF, Perkins DO. Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis. Brain, Behavior, and Immunity. PMID 30496778 DOI: 10.1016/J.Bbi.2018.11.315  0.338
2018 Ward HB, Lawson MT, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Jeffries CD, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Perkins DO. Tobacco use and psychosis risk in persons at clinical high risk. Early Intervention in Psychiatry. PMID 30362261 DOI: 10.1111/Eip.12751  0.379
2018 Romanowska S, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Neurocognitive deficits in a transdiagnostic clinical staging model. Psychiatry Research. PMID 30360915 DOI: 10.1016/J.Psychres.2018.10.030  0.66
2018 Carrión RE, Auther AM, McLaughlin D, Olsen R, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, et al. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis. Schizophrenia Bulletin. PMID 30351423 DOI: 10.1093/Schbul/Sby126  0.387
2018 Cadenhead KS, Minichino A, Kelsven S, Addington J, Bearden C, Cannon TD, Cornblatt BA, Mathalon D, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Yao J, et al. Metabolic abnormalities and low dietary Omega 3 are associated with symptom severity and worse functioning prior to the onset of psychosis: Findings from the North American Prodrome Longitudinal Studies Consortium. Schizophrenia Research. PMID 30249470 DOI: 10.1016/J.Schres.2018.09.022  0.387
2018 Cao H, Chén OY, Chung Y, Forsyth JK, McEwen SC, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, et al. Cerebello-thalamo-cortical hyperconnectivity as a state-independent functional neural signature for psychosis prediction and characterization. Nature Communications. 9: 3836. PMID 30242220 DOI: 10.1038/S41467-018-06350-7  0.372
2018 Cao H, McEwen SC, Chung Y, Chén OY, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, Perkins DO, Belger A, et al. Altered Brain Activation During Memory Retrieval Precedes and Predicts Conversion to Psychosis in Individuals at Clinical High Risk. Schizophrenia Bulletin. PMID 30215784 DOI: 10.1093/Schbul/Sby122  0.35
2018 Santesteban-Echarri O, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Family functioning in youth at-risk for serious mental illness. Comprehensive Psychiatry. 87: 17-24. PMID 30193153 DOI: 10.1016/J.Comppsych.2018.08.010  0.649
2018 Shakeel MK, Lu L, Cannon TD, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Walker EF, Mathalon DH, Bearden CE, Addington J. Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis. Schizophrenia Research. PMID 30181061 DOI: 10.1016/J.Schres.2018.08.032  0.336
2018 Addington J, Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Santesteban-Echarri O, Woods SW. Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis. Psychological Medicine. 1-8. PMID 30176955 DOI: 10.1017/S0033291718002258  0.44
2018 Santesteban-Echarri O, Piskulic D, Nyman RK, Addington J. Telehealth interventions for schizophrenia-spectrum disorders and clinical high-risk for psychosis individuals: A scoping review. Journal of Telemedicine and Telecare. 1357633X18794100. PMID 30134781 DOI: 10.1177/1357633X18794100  0.396
2018 Velthorst E, Meyer EC, Giuliano AJ, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Bearden CE, Seidman LJ. Neurocognitive profiles in the prodrome to psychosis in NAPLS-1. Schizophrenia Research. PMID 30078717 DOI: 10.1016/J.Schres.2018.07.038  0.374
2018 Farris MS, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Treatment History of Youth At-Risk for Serious Mental Illness. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743718792195. PMID 30071747 DOI: 10.1177/0706743718792195  0.647
2018 Addington J, Goldstein BI, Wang JL, Kennedy SH, Bray S, Lebel C, Hassel S, Marshall C, MacQueen G. Youth at-risk for serious mental illness: methods of the PROCAN study. Bmc Psychiatry. 18: 219. PMID 29976184 DOI: 10.1186/S12888-018-1801-0  0.653
2018 Chung Y, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, McEwen S, van Erp TGM, Cannon TD, et al. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk. Jama Psychiatry. PMID 29971330 DOI: 10.1001/Jamapsychiatry.2018.1543  0.387
2018 Hampton JN, Trotman HD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Tsuang MT, Perkins DO, Seidman LJ, Woods SW, Walker EF. The relation of atypical antipsychotic use and stress with weight in individuals at clinical high risk for psychosis. Stress and Health : Journal of the International Society For the Investigation of Stress. PMID 29956456 DOI: 10.1002/Smi.2819  0.311
2018 Devoe DJ, Farris MS, Townes P, Addington J. Interventions and social functioning in youth at risk of psychosis: A systematic review and meta-analysis. Early Intervention in Psychiatry. PMID 29938910 DOI: 10.1111/Eip.12689  0.332
2018 Correll CU, Galling B, Pawar A, Krivko A, Bonetto C, Ruggeri M, Craig TJ, Nordentoft M, Srihari VH, Guloksuz S, Hui CLM, Chen EYH, Valencia M, Juarez F, Robinson DG, ... ... Addington J, et al. Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression. Jama Psychiatry. PMID 29800949 DOI: 10.1001/Jamapsychiatry.2018.0623  0.323
2018 Davidson CA, Piskulic D, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Woods SW, Johannesen JK. Age-related trajectories of social cognition in youth at clinical high risk for psychosis: An exploratory study. Schizophrenia Research. PMID 29751984 DOI: 10.1016/J.Schres.2018.05.001  0.357
2018 Devoe DJ, Farris MS, Townes P, Addington J. Attenuated psychotic symptom interventions in youth at risk of psychosis: A systematic review and meta-analysis. Early Intervention in Psychiatry. PMID 29749710 DOI: 10.1111/Eip.12677  0.374
2018 Webb JR, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen RK, Seidman LJ, Woods SW. Erratum to: Specificity of incident diagnostic outcomes in patients at clinical high risk for psychosis Schizophrenia Bulletin. 44. PMID 29718467 DOI: 10.1093/Schbul/Sbx097  0.352
2018 Brodey BB, Girgis RR, Favorov OV, Addington J, Perkins DO, Bearden CE, Woods SW, Walker EF, Cornblatt BA, Brucato G, Walsh B, Elkin KA, Brodey IS. The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning. Schizophrenia Research. PMID 29358019 DOI: 10.1016/J.Schres.2017.11.030  0.358
2018 Chung Y, Addington J, Bearden C, Cadenhead K, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Seidman L, Tsuang M, Walker E, Woods S, McEwen S, van Erp T, Cannon T. S184. MACHINE LEARNING REVEALS DEVIANCE IN NEUROANATOMICAL MATURITY PREDICTIVE OF FUTURE PSYCHOSIS IN YOUTH AT CLINICAL HIGH RISK Schizophrenia Bulletin. 44: S396-S397. DOI: 10.1093/Schbul/Sby018.971  0.352
2018 Romanowska S, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. S80. NEUROCOGNITIVE FUNCTIONING IN YOUTH AT RISK OF SERIOUS MENTAL ILLNESS Schizophrenia Bulletin. 44: S355-S356. DOI: 10.1093/Schbul/Sby018.867  0.647
2018 Allswede D, Cannon T, Addington J, Bearden C, Cadenhead K, Cornblatt B, Mathalon D, Thomas M, Perkins D, Seidman L, Tsuang M, Walker E, Woods S. S244. CHARACTERIZING OUTCOMES OF CLINICAL HIGH-RISK NON-CONVERTERS USING GROUP-BASED TRAJECTORY MODELING Schizophrenia Bulletin. 44: S422-S422. DOI: 10.1093/Schbul/Sby018.1031  0.324
2018 Foss-Feig J, Velthorst E, Guillory S, Hamilton H, Roach B, Bachman P, Belger A, Carrion R, Duncan E, Johannesen J, Light G, Niznikiewicz M, Addington J, Cadenhead K, Cannon T, et al. F118. ARCHITECTURE OF PSYCHOSIS SYMPTOMS AND NEURAL PREDICTORS OF CONVERSION AMONG CLINICAL HIGH RISK INDIVIDUALS WITH AUTISM SPECTRUM DISORDER Schizophrenia Bulletin. 44: S266-S266. DOI: 10.1093/Schbul/Sby017.649  0.333
2018 Cullen A, Cadenhead KS, Addington J, Bearden CE, Cannon T, Cornblatt BA, Mathalon D, McGlashan TH, Perkins DO, Seidman L, Stone WS, Tsuang M, Woods SW, Walker EF. O9.8. STRESS AND COGNITIVE FUNCTION AMONG INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS: FINDINGS FROM THE NAPLS COHORT Schizophrenia Bulletin. 44: S102-S102. DOI: 10.1093/Schbul/Sby015.252  0.349
2018 Woodberry K, Stone WS, Shapiro DI, Chokran CM, Addington J, Bearden C, Cadenhead K, Cannon TD, Cornblatt BA, McGlashan TH, Mathalon DH, Perkins DO, Tsuang MT, Walker EF, Woods SW, et al. O2.8. TRAJECTORIES OF NEUROCOGNITIVE FUNCTIONING OVER TIME IN YOUTH AT CLINICAL HIGH RISK WHO DO AND DO NOT TRANSITION TO PSYCHOSIS Schizophrenia Bulletin. 44: S78-S78. DOI: 10.1093/Schbul/Sby015.198  0.341
2018 Velthorst E, Bearden C, Meyer E, Giuliano A, Addington J, Cadenhead K, Cannon T, Cornblatt B, Mcglashan T, Perkins D, Tsuang M, Walker E, Woods S, Seidman L. 24.2 NEUROCOGNITIVE PROFILES IN THE PRODROME TO PSYCHOSIS IN NAPLS-1 Schizophrenia Bulletin. 44: S39-S40. DOI: 10.1093/Schbul/Sby014.097  0.321
2018 Goldsmith D, Miller A, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Tsuang M, Woods S, Walker E. F236. Association of Baseline Tumor Necrosis Factor and the Development of Negative Symptoms in Individuals at Clinical High Risk for Psychosis Biological Psychiatry. 83: S330-S331. DOI: 10.1016/J.Biopsych.2018.02.850  0.362
2017 Ryan AT, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Cannon TD, Walker EF. Latent class cluster analysis of symptom ratings identifies distinct subgroups within the clinical high risk for psychosis syndrome. Schizophrenia Research. PMID 29279247 DOI: 10.1016/J.Schres.2017.12.001  0.371
2017 Brodey BB, Addington J, First MB, Perkins DO, Woods SW, Walker EF, Walsh B, Nieri JM, Nunn MB, Putz J, Brodey IS. The Early Psychosis Screener (EPS): Item development and qualitative validation. Schizophrenia Research. PMID 29254878 DOI: 10.1016/J.Schres.2017.11.027  0.324
2017 Piskulic D, Romanowska S, Addington J. Pilot study of cognitive remediation and motivational interviewing in youth at risk of serious mental illness. Early Intervention in Psychiatry. PMID 29164824 DOI: 10.1111/Eip.12520  0.396
2017 Devoe DJ, Peterson A, Addington J. Negative Symptom Interventions in Youth at Risk of Psychosis: A Systematic Review and Network Meta-analysis. Schizophrenia Bulletin. PMID 29069511 DOI: 10.1093/Schbul/Sbx139  0.379
2017 Healey KM, Penn DL, Perkins D, Woods SW, Keefe RSE, Addington J. Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk Prediction. Schizophrenia Bulletin. PMID 29036587 DOI: 10.1093/Schbul/Sbx080  0.386
2017 Woods SW, Powers AR, Taylor JH, Davidson CA, Johannesen JK, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups. Schizophrenia Bulletin. PMID 29036402 DOI: 10.1093/Schbul/Sbx138  0.377
2017 Fulford D, Piskulic D, Addington J, Kane JM, Schooler NR, Mueser KT. Prospective Relationships Between Motivation and Functioning in Recovery After a First Episode of Schizophrenia. Schizophrenia Bulletin. PMID 28981811 DOI: 10.1093/Schbul/Sbx096  0.375
2017 Lu Y, Marshall C, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. Perceptual abnormalities in clinical high risk youth and the role of trauma, cannabis use and anxiety. Psychiatry Research. PMID 28886901 DOI: 10.1016/J.Psychres.2017.08.045  0.38
2017 Tarbox-Berry SI, Perkins DO, Woods SW, Addington J. Premorbid social adjustment and association with attenuated psychotic symptoms in clinical high-risk and help-seeking youth. Psychological Medicine. 1-15. PMID 28874223 DOI: 10.1017/S0033291717002343  0.388
2017 Georgopoulos G, Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. The role of a family history of psychosis for youth at clinical high risk of psychosis. Early Intervention in Psychiatry. PMID 28792113 DOI: 10.1111/Eip.12471  0.41
2017 Marshall C, Lu Y, Lyngberg K, Deighton S, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, ... Addington J, et al. Changes in symptom content from a clinical high-risk state to conversion to psychosis. Early Intervention in Psychiatry. PMID 28771938 DOI: 10.1111/Eip.12473  0.381
2017 Addington J, Addington D, Abidi S, Raedler T, Remington G. CPA Treatment Guidelines for Individuals at Clinical High Risk of Psychosis. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743717719895. PMID 28730848 DOI: 10.1177/0706743717719895  0.382
2017 Nagendra A, Schooler NR, Kane JM, Robinson DG, Mueser KT, Estroff SE, Addington J, Marcy P, Penn DL. Demographic, psychosocial, clinical, and neurocognitive baseline characteristics of Black Americans in the RAISE-ETP study. Schizophrenia Research. PMID 28709773 DOI: 10.1016/J.Schres.2017.06.038  0.313
2017 Brunette MF, Mueser KT, Babbin S, Meyer-Kalos P, Rosenheck R, Correll CU, Cather C, Robinson DG, Schooler NR, Penn DL, Addington J, Estroff SE, Gottlieb J, Glynn SM, Marcy P, et al. Demographic and clinical correlates of substance use disorders in first episode psychosis. Schizophrenia Research. PMID 28697856 DOI: 10.1016/J.Schres.2017.06.039  0.38
2017 Kline ER, Seidman LJ, Cornblatt BA, Woodberry KA, Bryant C, Bearden CE, Cadenhead KS, Cannon TD, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Addington J. Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort. Schizophrenia Research. PMID 28578922 DOI: 10.1016/J.Schres.2017.05.032  0.332
2017 Browne J, Penn DL, Bauer DJ, Meyer-Kalos P, Mueser KT, Robinson DG, Addington J, Schooler NR, Glynn SM, Gingerich S, Marcy P, Kane JM. Perceived Autonomy Support in the NIMH RAISE Early Treatment Program. Psychiatric Services (Washington, D.C.). appips201600480. PMID 28566027 DOI: 10.1176/Appi.Ps.201600480  0.34
2017 Velthorst E, Zinberg J, Addington J, Cadenhead KS, Cannon TD, Carrión RE, Auther A, Cornblatt BA, McGlashan TH, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, et al. Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis. Development and Psychopathology. 1-9. PMID 28420458 DOI: 10.1017/S0954579417000451  0.337
2017 Addington J, Piskulic D, Liu L, Lockwood J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Woods SW. Comorbid diagnoses for youth at clinical high risk of psychosis. Schizophrenia Research. PMID 28372906 DOI: 10.1016/J.Schres.2017.03.043  0.407
2017 Chung Y, Haut KM, He G, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, et al. Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis. Schizophrenia Research. PMID 28245961 DOI: 10.1016/J.Schres.2017.02.014  0.348
2017 Zheutlin AB, Jeffries CD, Perkins DO, Chung Y, Chekroud AM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Walker EF, Woods SW, Tsuang M, et al. The Role of microRNA Expression in Cortical Development During Conversion to Psychosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28186095 DOI: 10.1038/Npp.2017.34  0.305
2017 Devoe D, Cadenhead K, Cannon T, Cornblatt B, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods S, Bearden C, Mathalon D, Addington J. SU127. Negative Symptoms in Youth at Clinical High Risk of Psychosis Schizophrenia Bulletin. 43: S207-S207. DOI: 10.1093/Schbul/Sbx024.123  0.405
2017 Carrion R, McLaughlin D, Auther A, Addington J, Bearden C, Cadenhead K, Cannon T, Tsuang M, Walker E, Woods SW, Cornblatt B. M118. Functional Capacity: A New Predictor of Role Functioning in Individuals at Clinical High Risk for Psychosis Schizophrenia Bulletin. 43: S253-S253. DOI: 10.1093/Schbul/Sbx022.112  0.347
2017 Mirzakhanian H, Sanchez S, Addington J, Bearden C, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, Cadenhead K. 209. Risk of Violence in Attenuated Psychosis Symptoms Syndrome and its Relationship With Symptomology Schizophrenia Bulletin. 43: S106-S107. DOI: 10.1093/Schbul/Sbx021.287  0.412
2017 Davidson C, Piskulic D, Addington J, Cadenhead K, Cannon T, Cornblatt B, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Bearden C, Mathalon D, Woods S, Johannesen J. 192. Different Age-Related Trajectories of Social Cognition in Youths at Clinical High Risk of Psychosis Schizophrenia Bulletin. 43: S100-S101. DOI: 10.1093/Schbul/Sbx021.270  0.37
2017 Burrell H, Lawson M, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, Jeffries C, Mathalon D, McGlashan T, Seidman L, Tsuang M, Walker E, Woods S, Perkins D. 155. Tobacco Use and Psychosis Risk in Persons at Clinical High Risk Schizophrenia Bulletin. 43: S80-S80. DOI: 10.1093/Schbul/Sbx021.213  0.365
2017 Auther A, Carrion R, McLaughlin D, Addington J, Bearden C, Cadenhead K, Cannon T, Mathalon D, McGlashan TH, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods S, Cornblatt B. 100. Converging Evidence for Social Functioning Deficits as a Neurodevelopmental Risk Factor in High-Risk Youth Schizophrenia Bulletin. 43: S53-S53. DOI: 10.1093/Schbul/Sbx021.138  0.358
2017 Hamilton H, Bachman P, Belger A, Carrion R, Duncan E, Johannesen J, Light G, Niznikiewicz M, Roach B, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, McGlashan T, et al. 80. Auditory Target Processing Deficits in Individuals at Clinical High Risk for Psychosis Schizophrenia Bulletin. 43: S45-S45. DOI: 10.1093/Schbul/Sbx021.119  0.343
2017 Jeffries C, Perkins D, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Seidman LJ, Tsuang M, Walker E, Woods S. 59.4 Networks of Blood Analytes are Collectively Informative of Risk of Conversion to Schizophrenia Schizophrenia Bulletin. 43: S33-S33. DOI: 10.1093/Schbul/Sbx021.086  0.32
2017 Velthorst E, Bearden C, Addington J, Cadenhead K, Cannon T, Carrion R, Auther A, Cornblatt B, McGlashan T, Mathalon D, Perkins D, Tsuang M, Walker E, Woods S, Meyer E, et al. 42. Heterogeneity of Neuropsychological Profiles in the Prodrome to Psychosis: An Examination of the Association Between Cognition and Clinical Outcomes in NAPLS-1 Schizophrenia Bulletin. 43: S23-S24. DOI: 10.1093/Schbul/Sbx021.061  0.326
2017 Cadenhead K, Addington J, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods S. 23. Omega-3 Fatty Acid Versus Placebo in a Clinical High-Risk Sample From the North American Prodrome Longitudinal Studies (NAPLS) Consortium Schizophrenia Bulletin. 43: S16-S16. DOI: 10.1093/Schbul/Sbx021.042  0.307
2017 Kelsven S, Addington J, Bearden C, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Seidman L, Walker E, Woods S, Cadenhead K. 20. Metabolic Abnormalities and Omega-3 Fatty Acids in Latinos at Clinical High Risk for Psychosis Schizophrenia Bulletin. 43: S14-S15. DOI: 10.1093/Schbul/Sbx021.039  0.3
2016 Jeffries CD, Perkins DO, Chandler SD, Stark T, Yeo E, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Walker EF, Woods SW, et al. Insights into psychosis risk from leukocyte microRNA expression. Translational Psychiatry. 6: e981. PMID 27959328 DOI: 10.1038/Tp.2016.148  0.316
2016 Browne J, Penn DL, Meyer-Kalos PS, Mueser KT, Estroff SE, Brunette MF, Correll CU, Robinson J, Rosenheck RA, Schooler N, Robinson DG, Addington J, Marcy P, Kane JM. Psychological well-being and mental health recovery in the NIMH RAISE early treatment program. Schizophrenia Research. PMID 27913160 DOI: 10.1016/J.Schres.2016.11.032  0.358
2016 Seidman LJ, Shapiro DI, Stone WS, Woodberry KA, Ronzio A, Cornblatt BA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, et al. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study. Jama Psychiatry. PMID 27806157 DOI: 10.1001/Jamapsychiatry.2016.2479  0.428
2016 Addington J, Liu L, Perkins DO, Carrion RE, Keefe RS, Woods SW. The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms. Schizophrenia Bulletin. PMID 27798225 DOI: 10.1093/Schbul/Sbw152  0.342
2016 Kuang C, Buchy L, Barbato M, Makowski C, MacMaster FP, Bray S, Deighton S, Addington J. A pilot study of cognitive insight and structural covariance in first-episode psychosis. Schizophrenia Research. PMID 27720314 DOI: 10.1016/J.Schres.2016.09.036  0.303
2016 Woodberry KA, Seidman LJ, Bryant C, Addington J, Bearden CE, S Cadenhead K, Cannon TD, Cornblatt BA, McGlashan TH, Mathalon DH, Perkins DO, Tsuang MT, Walker EF, Woods SW. Treatment Precedes Positive Symptoms in North American Adolescent and Young Adult Clinical High Risk Cohort. Journal of Clinical Child and Adolescent Psychology : the Official Journal For the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53. 1-10. PMID 27705009 DOI: 10.1080/15374416.2016.1212361  0.422
2016 Cannon TD, Yu C, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Heinssen R, Jeffries CD, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, et al. An Individualized Risk Calculator for Research in Prodromal Psychosis. The American Journal of Psychiatry. appiajp201615070890. PMID 27363508 DOI: 10.1176/Appi.Ajp.2016.15070890  0.371
2016 Buchy L, Mathalon DH, Cannon TD, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Addington J. Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis. Psychiatry Research. 254: 3-9. PMID 27289213 DOI: 10.1016/J.Pscychresns.2016.06.001  0.305
2016 Marshall C, Deighton S, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. The Violent Content in Attenuated Psychotic Symptoms. Psychiatry Research. 242: 61-66. PMID 27259137 DOI: 10.1016/J.Psychres.2016.05.005  0.346
2016 Deighton S, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. Traumatic brain injury in individuals at clinical high risk for psychosis. Schizophrenia Research. PMID 27165121 DOI: 10.1016/J.Schres.2016.04.041  0.353
2016 McLaughlin D, Carrión RE, Auther AM, Olvet DM, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Heinssen RK, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, et al. Functional Capacity Assessed by the Map Task in Individuals at Clinical High-Risk for Psychosis. Schizophrenia Bulletin. PMID 27105902 DOI: 10.1093/Schbul/Sbw039  0.392
2016 Moskow DM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Heinssen R, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Cannon TD, Woods SW, Walker EF. The relations of age and pubertal development with cortisol and daily stress in youth at clinical risk for psychosis. Schizophrenia Research. PMID 26905038 DOI: 10.1016/J.Schres.2016.02.002  0.324
2016 Stone WS, Mesholam-Gately RI, Giuliano AJ, Woodberry KA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, et al. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers. Schizophrenia Research. PMID 26896388 DOI: 10.1016/J.Schres.2016.02.003  0.39
2016 Drake RJ, Addington J, Viswanathan AC, Lewis SW, Cotter J, Yung AR, Abel KM. How age and gender predict illness course in a first-episode nonaffective psychosis cohort. The Journal of Clinical Psychiatry. PMID 26890690 DOI: 10.4088/Jcp.14M09369  0.342
2016 Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Early traumatic experiences, perceived discrimination and conversion to psychosis in those at clinical high risk for psychosis. Social Psychiatry and Psychiatric Epidemiology. PMID 26851943 DOI: 10.1007/S00127-016-1182-Y  0.409
2016 Piskulic D, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort. Schizophrenia Research. PMID 26785807 DOI: 10.1016/J.Schres.2016.01.017  0.355
2016 Marulanda S, Addington J. Resilience in individuals at clinical high risk for psychosis. Early Intervention in Psychiatry. 10: 212-9. PMID 25234104 DOI: 10.1111/Eip.12174  0.428
2015 Barbato M, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Heinssen R, Addington J. Theory of Mind, Emotion Recognition and Social Perception in Individuals at Clinical High Risk for Psychosis: findings from the NAPLS-2 cohort. Schizophrenia Research. Cognition. 2: 133-139. PMID 27695675 DOI: 10.1016/J.Scog.2015.04.004  0.318
2015 Fusar-Poli P, Cappucciati M, Borgwardt S, Woods SW, Addington J, Nelson B, Nieman DH, Stahl DR, Rutigliano G, Riecher-Rössler A, Simon AE, Mizuno M, Lee TY, Kwon JS, Lam MM, et al. Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification. Jama Psychiatry. 1-8. PMID 26719911 DOI: 10.1001/Jamapsychiatry.2015.2324  0.399
2015 Buchy L, Seidman LJ, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Stone W, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis. Psychiatry Research. PMID 26626949 DOI: 10.1016/J.Psychres.2015.11.033  0.344
2015 Fusar-Poli P, Schultze-Lutter F, Cappucciati M, Rutigliano G, Bonoldi I, Stahl D, Borgwardt S, Riecher-Rössler A, Addington J, Perkins DO, Woods SW, McGlashan T, Lee J, Klosterkötter J, Yung AR, et al. The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis. Schizophrenia Bulletin. PMID 26591006 DOI: 10.1093/Schbul/Sbv162  0.372
2015 Lyngberg K, Buchy L, Liu L, Perkins D, Woods S, Addington J. Patterns of premorbid functioning in individuals at clinical high risk of psychosis. Schizophrenia Research. PMID 26589390 DOI: 10.1016/J.Schres.2015.11.004  0.402
2015 Buchy L, Cannon TD, Anticevic A, Lyngberg K, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis. Bmc Psychiatry. 15: 276. PMID 26553191 DOI: 10.1186/S12888-015-0656-X  0.347
2015 McAusland L, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Anxiety in youth at clinical high risk for psychosis. Early Intervention in Psychiatry. PMID 26456932 DOI: 10.1111/Eip.12274  0.347
2015 Perkins DO, Jeffries CD, Cornblatt BA, Woods SW, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Heinssen R, Mathalon DH, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Severity of thought disorder predicts psychosis in persons at clinical high-risk. Schizophrenia Research. PMID 26441004 DOI: 10.1016/J.Schres.2015.09.008  0.378
2015 Trampush JW, Lencz T, DeRosse P, John M, Gallego JA, Petrides G, Hassoun Y, Zhang JP, Addington J, Kellner CH, Tohen M, Burdick KE, Goldberg TE, Kane JM, Robinson DG, et al. Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders. Schizophrenia Bulletin. PMID 26409223 DOI: 10.1093/Schbul/Sbv120  0.366
2015 Fusar-Poli P, Cappucciati M, Rutigliano G, Schultze-Lutter F, Bonoldi I, Borgwardt S, Riecher-Rössler A, Addington J, Perkins D, Woods SW, McGlashan TH, Lee J, Klosterkötter J, Yung AR, McGuire P. At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 14: 322-32. PMID 26407788 DOI: 10.1002/Wps.20250  0.374
2015 Robinson DG, Gallego JA, John M, Petrides G, Hassoun Y, Zhang JP, Lopez L, Braga RJ, Sevy SM, Addington J, Kellner CH, Tohen M, Naraine M, Bennett N, Greenberg J, et al. A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes. Schizophrenia Bulletin. PMID 26338693 DOI: 10.1093/Schbul/Sbv125  0.358
2015 Zhang JP, Robinson DG, Gallego JA, John M, Yu J, Addington J, Tohen M, Kane JM, Malhotra AK, Lencz T. Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis. Schizophrenia Bulletin. PMID 26320194 DOI: 10.1093/Schbul/Sbv116  0.33
2015 Webb JR, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen RK, Seidman LJ, Tarbox SI, Tsuang MT, Walker EF, McGlashan TH, Woods SW. Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis. Schizophrenia Bulletin. 41: 1066-75. PMID 26272875 DOI: 10.1093/Schbul/Sbv091  0.358
2015 Anticevic A, Haut K, Murray JD, Repovs G, Yang GJ, Diehl C, McEwen SC, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet D, Mathalon DH, et al. Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk. Jama Psychiatry. PMID 26267151 DOI: 10.1001/Jamapsychiatry.2015.0566  0.418
2015 Buchy L, Stowkowy J, MacMaster FP, Nyman K, Addington J. Meta-cognition is associated with cortical thickness in youth at clinical high risk of psychosis. Psychiatry Research. 233: 418-23. PMID 26210694 DOI: 10.1016/J.Pscychresns.2015.07.010  0.336
2015 Waford RN, MacDonald A, Goines K, Novacek DM, Trotman HD, Elaine F W, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Mathalon DH, Tsuang MT, Perkins DO, et al. Demographic correlates of attenuated positive psychotic symptoms. Schizophrenia Research. PMID 25999040 DOI: 10.1016/J.Schres.2015.04.035  0.361
2015 Addington J, Liu L, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, McGlashan TH. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms. The Journal of Nervous and Mental Disease. 203: 328-35. PMID 25919383 DOI: 10.1097/Nmd.0000000000000290  0.352
2015 Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Heinssen R, Addington J. Core Schemas in Youth at Clinical High Risk for Psychosis. Behavioural and Cognitive Psychotherapy. 1-11. PMID 25896713 DOI: 10.1017/S1352465815000144  0.38
2015 Kane JM, Schooler NR, Marcy P, Correll CU, Brunette MF, Mueser KT, Rosenheck RA, Addington J, Estroff SE, Robinson J, Penn DL, Robinson DG. The RAISE early treatment program for first-episode psychosis: background, rationale, and study design. The Journal of Clinical Psychiatry. 76: 240-6. PMID 25830446 DOI: 10.4088/Jcp.14M09289  0.366
2015 Mueser KT, Penn DL, Addington J, Brunette MF, Gingerich S, Glynn SM, Lynde DW, Gottlieb JD, Meyer-Kalos P, McGurk SR, Cather C, Saade S, Robinson DG, Schooler NR, Rosenheck RA, et al. The NAVIGATE Program for First-Episode Psychosis: Rationale, Overview, and Description of Psychosocial Components. Psychiatric Services (Washington, D.C.). 66: 680-90. PMID 25772766 DOI: 10.1176/Appi.Ps.201400413  0.31
2015 Robinson DG, Schooler NR, John M, Correll CU, Marcy P, Addington J, Brunette MF, Estroff SE, Mueser KT, Penn D, Robinson J, Rosenheck RA, Severe J, Goldstein A, Azrin S, et al. Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study. The American Journal of Psychiatry. 172: 237-48. PMID 25727536 DOI: 10.1176/Appi.Ajp.2014.13101355  0.336
2015 Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R, Bearden CE, Mathalon D, Addington J. Substance use in individuals at clinical high risk of psychosis. Psychological Medicine. 45: 2275-84. PMID 25727300 DOI: 10.1017/S0033291715000227  0.391
2015 Addington J, Heinssen RK, Robinson DG, Schooler NR, Marcy P, Brunette MF, Correll CU, Estroff S, Mueser KT, Penn D, Robinson JA, Rosenheck RA, Azrin ST, Goldstein AB, Severe J, et al. Duration of Untreated Psychosis in Community Treatment Settings in the United States. Psychiatric Services (Washington, D.C.). 66: 753-6. PMID 25588418 DOI: 10.1176/Appi.Ps.201400124  0.342
2015 Auther AM, Cadenhead KS, Carrión RE, Addington J, Bearden CE, Cannon TD, McGlashan TH, Perkins DO, Seidman L, Tsuang M, Walker EF, Woods SW, Cornblatt BA. Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample. Acta Psychiatrica Scandinavica. 132: 60-8. PMID 25572323 DOI: 10.1111/Acps.12382  0.371
2015 Piskulic D, Barbato M, Liu L, Addington J. Pilot study of cognitive remediation therapy on cognition in young people at clinical high risk of psychosis Psychiatry Research. 225: 93-98. PMID 25467705 DOI: 10.1016/J.Psychres.2014.10.021  0.337
2015 Addington J, Stowkowy J, Weiser M. Screening tools for clinical high risk for psychosis. Early Intervention in Psychiatry. 9: 345-56. PMID 25345316 DOI: 10.1111/Eip.12193  0.334
2015 Addington J, van der Gaag M. Psychosocial treatments for clinical high risk individuals. Schizophrenia Bulletin. 41: 22. PMID 25316912 DOI: 10.1093/Schbul/Sbu140  0.435
2015 Perkins DO, Jeffries CD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R. Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project. Schizophrenia Bulletin. 41: 419-28. PMID 25103207 DOI: 10.1093/Schbul/Sbu099  0.364
2015 Cannon TD, Chung Y, He G, Sun D, Jacobson A, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Jeffries C, et al. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biological Psychiatry. 77: 147-57. PMID 25034946 DOI: 10.1016/J.Biopsych.2014.05.023  0.411
2015 Deighton S, Addington J. Exercise practices in individuals at clinical high risk of developing psychosis. Early Intervention in Psychiatry. 9: 284-91. PMID 24252093 DOI: 10.1111/Eip.12107  0.354
2014 Correll CU, Robinson DG, Schooler NR, Brunette MF, Mueser KT, Rosenheck RA, Marcy P, Addington J, Estroff SE, Robinson J, Penn DL, Azrin S, Goldstein A, Severe J, Heinssen R, et al. Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study. Jama Psychiatry. 71: 1350-63. PMID 25321337 DOI: 10.1001/Jamapsychiatry.2014.1314  0.397
2014 Miklowitz DJ, O'Brien MP, Schlosser DA, Addington J, Candan KA, Marshall C, Domingues I, Walsh BC, Zinberg JL, De Silva SD, Friedman-Yakoobian M, Cannon TD. Family-focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry. 53: 848-58. PMID 25062592 DOI: 10.1016/J.Jaac.2014.04.020  0.416
2014 Marshall C, Denny E, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Walker E, Addington J. The content of attenuated psychotic symptoms in those at clinical high risk for psychosis. Psychiatry Research. 219: 506-12. PMID 25048759 DOI: 10.1016/J.Psychres.2014.06.023  0.372
2014 Woods SW, Walsh BC, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tarbox SI, Tsuang MT, Walker EF, McGlashan TH. Current status specifiers for patients at clinical high risk for psychosis. Schizophrenia Research. 158: 69-75. PMID 25012147 DOI: 10.1016/J.Schres.2014.06.022  0.382
2014 Stowkowy J, Perkins DO, Woods SW, Nyman K, Addington J. Personal Beliefs about Experiences in those at Clinical High Risk for Psychosis. Behavioural and Cognitive Psychotherapy. 1-7. PMID 24949991 DOI: 10.1017/S1352465814000307  0.418
2014 Buchy L, Perkins D, Woods SW, Liu L, Addington J. Impact of substance use on conversion to psychosis in youth at clinical high risk of psychosis. Schizophrenia Research. 156: 277-80. PMID 24837058 DOI: 10.1016/J.Schres.2014.04.021  0.354
2014 Yong E, Barbato M, Penn DL, Keefe RS, Woods SW, Perkins DO, Addington J. Exploratory analysis of social cognition and neurocognition in individuals at clinical high risk for psychosis. Psychiatry Research. 218: 39-43. PMID 24755041 DOI: 10.1016/J.Psychres.2014.04.003  0.348
2014 Lecomte T, Corbière M, Ehmann T, Addington J, Abdel-Baki A, Macewan B. Development and preliminary validation of the First Episode Social Functioning Scale for early psychosis. Psychiatry Research. 216: 412-7. PMID 24613006 DOI: 10.1016/J.Psychres.2014.01.044  0.301
2014 Alderman T, Addington J, Bearden C, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cadenhead KS. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium. Early Intervention in Psychiatry. PMID 24576057 DOI: 10.1111/Eip.12128  0.409
2014 Meyer EC, Carrión RE, Cornblatt BA, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Heinssen R, Seidman LJ. The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study. Schizophrenia Bulletin. 40: 1452-61. PMID 24550526 DOI: 10.1093/Schbul/Sbt235  0.405
2014 Addington J, Shah H, Liu L, Addington D. Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis. Schizophrenia Research. 153: 64-7. PMID 24439270 DOI: 10.1016/J.Schres.2013.12.014  0.37
2014 Addington J, Case N, Saleem MM, Auther AM, Cornblatt BA, Cadenhead KS. Substance use in clinical high risk for psychosis: a review of the literature. Early Intervention in Psychiatry. 8: 104-12. PMID 24224849 DOI: 10.1111/Eip.12100  0.396
2014 Tarbox SI, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Heinssen R, McGlashan TH, Woods SW. Functional development in clinical high risk youth: prediction of schizophrenia versus other psychotic disorders. Psychiatry Research. 215: 52-60. PMID 24200216 DOI: 10.1016/J.Psychres.2013.10.006  0.43
2014 Barbato M, Addington J. Binocular depth perception in individuals at clinical high risk for psychosis: No evidence of dysfunction Neuropsychology. 28: 366-372. PMID 24188117 DOI: 10.1037/Neu0000033  0.371
2014 Saleem MM, Stowkowy J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Addington J. Perceived discrimination in those at clinical high risk for psychosis. Early Intervention in Psychiatry. 8: 77-81. PMID 23773288 DOI: 10.1111/Eip.12058  0.366
2014 Barbato M, Penn DL, Perkins DO, Woods SW, Liu L, Addington J. Metacognitive functioning in individuals at clinical high risk for psychosis. Behavioural and Cognitive Psychotherapy. 42: 526-34. PMID 23517866 DOI: 10.1017/S1352465813000167  0.407
2014 Cadenhead K, Addington J, Bearden CE, Cannon T, McGlashan T, Mathalon D, Perkins D, Seidman LI, Tsuang M, Walker E, Woods S. Poster #T38 PREDICTION OF SYMPTOM OUTCOME IN CLINICAL HIGH RISK SUBJECTS USING THE ACOUSTIC STARTLE PARADIGM Schizophrenia Research. 153: S302-S303. DOI: 10.1016/S0920-9964(14)70855-2  0.338
2014 Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LI, Valmaggia L, Cannon T, Velthorst E, Haan Ld, Cornblatt B, et al. The Psychosis High Risk State: Is It Valid? Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70075-1  0.333
2014 Piskulic D, Barbato M, Liu L, Addington J. Poster #M79 EFFECTS OF COGNITIVE REMEDIATION ON COGNITION IN YOUNG PEOPLE AT CLINICAL HIGH RISK OF PSYCHOSIS Schizophrenia Research. 153: S218. DOI: 10.1016/S0920-9964(12)70739-9  0.337
2013 Tarbox SI, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Heinssen R, McGlashan TH, Woods SW. Premorbid functional development and conversion to psychosis in clinical high-risk youths. Development and Psychopathology. 25: 1171-86. PMID 24229556 DOI: 10.1017/S0954579413000448  0.431
2013 Healey KM, Penn DL, Perkins D, Woods SW, Addington J. Theory of mind and social judgments in people at clinical high risk of psychosis. Schizophrenia Research. 150: 498-504. PMID 24055202 DOI: 10.1016/J.Schres.2013.08.038  0.345
2013 Barbato M, Liu L, Penn DL, Keefe RS, Perkins DO, Woods SW, Addington J. Social cognition as a mediator between neurocognition and functional outcome in individuals at clinical high risk for psychosis. Schizophrenia Research. 150: 542-6. PMID 24012459 DOI: 10.1016/J.Schres.2013.08.015  0.32
2013 Woods SW, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011. Schizophrenia Research. 148: 99-104. PMID 23787224 DOI: 10.1016/J.Schres.2013.05.019  0.362
2013 Addington DE, Patten SB, McKenzie E, Addington J. Relationship between relapse and hospitalization in first-episode psychosis. Psychiatric Services (Washington, D.C.). 64: 796-9. PMID 23632466 DOI: 10.1176/Appi.Ps.201200440  0.308
2013 Stowkowy J, Addington J. Predictors of a clinical high risk status among individuals with a family history of psychosis. Schizophrenia Research. 147: 281-6. PMID 23611242 DOI: 10.1016/J.Schres.2013.03.030  0.399
2013 Walker EF, Trotman HD, Pearce BD, Addington J, Cadenhead KS, Cornblatt BA, Heinssen R, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Cannon TD, McGlashan TH, Woods SW. Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study. Biological Psychiatry. 74: 410-7. PMID 23562006 DOI: 10.1016/J.Biopsych.2013.02.016  0.388
2013 Addington J, Stowkowy J, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon TD. Early traumatic experiences in those at clinical high risk for psychosis. Early Intervention in Psychiatry. 7: 300-5. PMID 23343384 DOI: 10.1111/Eip.12020  0.407
2013 Magaud E, Nyman K, Addington J. Cyberbullying in those at clinical high risk for psychosis. Early Intervention in Psychiatry. 7: 427-30. PMID 23343259 DOI: 10.1111/Eip.12013  0.391
2013 Walder DJ, Holtzman CW, Addington J, Cadenhead K, Tsuang M, Cornblatt B, Cannon TD, McGlashan TH, Woods SW, Perkins DO, Seidman LJ, Heinssen R, Walker EF. Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome. Schizophrenia Research. 144: 43-50. PMID 23340377 DOI: 10.1016/J.Schres.2012.11.039  0.358
2013 Addington J. Identifying a treatable psychosis-risk cohort. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 58: 3-4. PMID 23327749 DOI: 10.1177/070674371305800102  0.489
2013 Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LJ, Valmaggia L, Cannon T, Velthorst E, De Haan L, Cornblatt B, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. Jama Psychiatry. 70: 107-20. PMID 23165428 DOI: 10.1001/Jamapsychiatry.2013.269  0.349
2013 Barbato M, Colijn MA, Keefe RS, Perkins DO, Woods SW, Hawkins KA, Christensen BK, Addington J. The course of cognitive functioning over six months in individuals at clinical high risk for psychosis. Psychiatry Research. 206: 195-9. PMID 23159196 DOI: 10.1016/J.Psychres.2012.10.013  0.346
2013 Addington J, McGregor L, Marulanda D, Raedler T. Recruitment strategies for the detection of individuals at clinical high risk of developing psychosis. Epidemiology and Psychiatric Sciences. 22: 181-5. PMID 23114021 DOI: 10.1017/S2045796012000583  0.357
2013 Brummitt K, Addington J. Treatment possibilities for individuals at clinical high risk of psychosis. Early Intervention in Psychiatry. 7: 155-61. PMID 22741811 DOI: 10.1111/J.1751-7893.2012.00370.X  0.388
2013 Stowkowy J, Colijn MA, Addington J. Pathways to care for those at clinical high risk of developing psychosis. Early Intervention in Psychiatry. 7: 80-3. PMID 22741608 DOI: 10.1111/J.1751-7893.2012.00368.X  0.322
2013 Boydell KM, Volpe T, Gladstone BM, Stasiulis E, Addington J. Youth at ultra high risk for psychosis: using the Revised Network Episode Model to examine pathways to mental health care. Early Intervention in Psychiatry. 7: 170-86. PMID 22390350 DOI: 10.1111/J.1751-7893.2012.00350.X  0.34
2012 Addington J, Barbato M. The role of cognitive functioning in the outcome of those at clinical high risk for developing psychosis Epidemiology and Psychiatric Sciences. 21: 335-342. PMID 23174394 DOI: 10.1017/S204579601200042X  0.363
2012 Yung AR, Woods SW, Ruhrmann S, Addington J, Schultze-Lutter F, Cornblatt BA, Amminger GP, Bechdolf A, Birchwood M, Borgwardt S, Cannon TD, de Haan L, French P, Fusar-Poli P, Keshavan M, et al. Whither the attenuated psychosis syndrome? Schizophrenia Bulletin. 38: 1130-4. PMID 23144056 DOI: 10.1093/Schbul/Sbs108  0.423
2012 Addington J, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Addington JA, Cannon TD. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophrenia Research. 142: 77-82. PMID 23043872 DOI: 10.1016/J.Schres.2012.09.012  0.349
2012 Piskulic D, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, McGlashan TH. Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Research. 196: 220-4. PMID 22445704 DOI: 10.1016/J.Psychres.2012.02.018  0.364
2012 Addington J, Lecomte T. Cognitive behaviour therapy for schizophrenia. F1000 Medicine Reports. 4: 6. PMID 22403587 DOI: 10.3410/M4-6  0.382
2012 Addington J, Marshall C, French P. Cognitive behavioral therapy in prodromal psychosis. Current Pharmaceutical Design. 18: 558-65. PMID 22239588 DOI: 10.2174/138161212799316082  0.331
2012 Addington J, Heinssen R. Prediction and prevention of psychosis in youth at clinical high risk. Annual Review of Clinical Psychology. 8: 269-89. PMID 22224837 DOI: 10.1146/Annurev-Clinpsy-032511-143146  0.435
2012 Gee DG, Karlsgodt KH, van Erp TG, Bearden CE, Lieberman MD, Belger A, Perkins DO, Olvet DM, Cornblatt BA, Constable T, Woods SW, Addington J, Cadenhead KS, McGlashan TH, Seidman LJ, et al. Altered age-related trajectories of amygdala-prefrontal circuitry in adolescents at clinical high risk for psychosis: a preliminary study. Schizophrenia Research. 134: 1-9. PMID 22056201 DOI: 10.1016/J.Schres.2011.10.005  0.358
2012 Marshall C, Addington J, Epstein I, Liu L, Deighton S, Zipursky RB. Treating young individuals at clinical high risk for psychosis. Early Intervention in Psychiatry. 6: 60-8. PMID 21951980 DOI: 10.1111/j.1751-7893.2011.00299.x  0.322
2012 Stowkowy J, Addington J. Maladaptive schemas as a mediator between social defeat and positive symptoms in young people at clinical high risk for psychosis. Early Intervention in Psychiatry. 6: 87-90. PMID 21951894 DOI: 10.1111/J.1751-7893.2011.00297.X  0.338
2012 Colijn MA, Barbato M, Keefe RS, Perkins DO, Woods SW, Addington J. Poster #143 AT RISK FOR PSYCHOSIS: THE ROLE OF COGNITION Schizophrenia Research. 136: S237. DOI: 10.1016/S0920-9964(12)70715-6  0.349
2012 Stowkowv l, Addington J. Poster #239 FAMILY HISTORY OF PSYCHOSIS, SOCIAL RISK FACTORS AND RISK OF DEVELOPING PSYCHOSIS Schizophrenia Research. 136: S177. DOI: 10.1016/S0920-9964(12)70552-2  0.362
2012 Piskulic D, Penn D, Perkins D, Woods S, Liu L, Addington J. Poster #162 AFFECT RECOGNITION IN PEOPLE AT CLINICAL HIGH RISK OF PSYCHOSIS Schizophrenia Research. 136: S149-S150. DOI: 10.1016/S0920-9964(12)70476-0  0.368
2011 Menon M, Schmitz TW, Anderson AK, Graff A, Korostil M, Mamo D, Gerretsen P, Addington J, Remington G, Kapur S. Exploring the neural correlates of delusions of reference. Biological Psychiatry. 70: 1127-33. PMID 21831358 DOI: 10.1016/J.Biopsych.2011.05.037  0.31
2011 Addington J, Cornblatt BA, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R. At clinical high risk for psychosis: outcome for nonconverters. The American Journal of Psychiatry. 168: 800-5. PMID 21498462 DOI: 10.1176/Appi.Ajp.2011.10081191  0.435
2011 Pencer A, Addington J. Reasons for using substances in adolescents with and without psychosis. Early Intervention in Psychiatry. 2: 42-4. PMID 21352130 DOI: 10.1111/J.1751-7893.2007.00055.X  0.772
2011 Addington J. The promise of early intervention. Early Intervention in Psychiatry. 1: 294-307. PMID 21352118 DOI: 10.1111/J.1751-7893.2007.00043.X  0.342
2011 Addington J, Epstein I, Liu L, French P, Boydell KM, Zipursky RB. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophrenia Research. 125: 54-61. PMID 21074974 DOI: 10.1016/J.Schres.2010.10.015  0.381
2010 Cadenhead KS, Addington J, Cannon T, Cornblatt B, McGlashan T, Perkins D, Seidman L, Tsuang M, Walker E, Woods S, Heinssen R. Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort. Early Intervention in Psychiatry. 4: 220-6. PMID 20712727 DOI: 10.1111/J.1751-7893.2010.00183.X  0.41
2010 Seidman LJ, Giuliano AJ, Meyer EC, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Bearden CE, Christensen BK, Hawkins K, Heaton R, et al. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Archives of General Psychiatry. 67: 578-88. PMID 20530007 DOI: 10.1016/J.Schres.2010.02.210  0.428
2010 Addington J, Piskulic D. Social cognition and functional outcome are separate domains in schizophrenia. Schizophrenia Research. 127: 262-3. PMID 20471225 DOI: 10.1016/J.Schres.2010.04.005  0.324
2010 Addington J, Girard TA, Christensen BK, Addington D. Social cognition mediates illness-related and cognitive influences on social function in patients with schizophrenia-spectrum disorders. Journal of Psychiatry & Neuroscience : Jpn. 35: 49-54. PMID 20040246 DOI: 10.1503/Jpn.080039  0.322
2010 Pencer A, Addington J. Models of substance use in adolescents with and without psychosis. Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal De L'Academie Canadienne De Psychiatrie De L'Enfant Et De L'Adolescent. 17: 202-9. PMID 19018323  0.782
2010 Piskulic D, Addington J, Maruff P. SOCIAL COGNITION IN SCHIZOPHRENIA: A QUANTITATIVE REVIEW OF THE LITERATURE Schizophrenia Research. 117: 413-414. DOI: 10.1016/J.Schres.2010.02.760  0.314
2010 Holtzman CW, Larson MK, Addington J, Cadenhead K, Cannon TD, Cornblatt B, Heinssen R, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Woods SW, Walker EF. SEX DIFFERENCES IN SYMPTOM PRESENTATION IN INDIVIDUALS AT RISK FOR PSYCHOSIS Schizophrenia Research. 117: 304-305. DOI: 10.1016/J.Schres.2010.02.508  0.37
2010 Addington J, Cornblatt B, Cadenhead K, Cannon T, Heinssen R, McGlashan T, Perkins D, Tsuang M, Walker E, Woods S, Seidman L. CLINICAL HIGH RISK FOR PSYCHOSIS: THE RISK OF FALSE POSITIVE Schizophrenia Research. 117: 279. DOI: 10.1016/J.Schres.2010.02.452  0.366
2010 Mizrahi R, Addington J, Rusjan P, Ivonne S, Isabelle B, Ng A, Pruessner J, Remington G, Houle S, Wilson AA. STRESS-INDUCED DOPAMINE RELEASE IN SUBJECTS AT CLINICAL HIGH RISK FOR PSYCHOSIS AND IN ANTIPSYCHOTIC NAIVE PATIENTS WITH PSYCHOSIS: A [11C]-(+)-PHNO PET STUDY Schizophrenia Research. 117: 173-174. DOI: 10.1016/J.Schres.2010.02.204  0.306
2010 Piskulic D, Addington J. SOCIAL COGNITION AND FUNCTIONAL OUTCOME AS SEPARATE DOMAINS IN SCHIZOPHRENIA Schizophrenia Research. 117: 528. DOI: 10.1016/J.Schres.2010.02.1017  0.334
2009 Addington J, Addington D. Three-year outcome of treatment in an early psychosis program. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 54: 626-30. PMID 19751551 DOI: 10.1177/070674370905400907  0.35
2009 Walker EF, Cornblatt BA, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Heinssen R. The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample. Schizophrenia Research. 115: 50-7. PMID 19709859 DOI: 10.1016/J.Schres.2009.07.023  0.351
2009 Addington J, Mancuso E. Cognitive-behavioral therapy for individuals at high risk of developing psychosis. Journal of Clinical Psychology. 65: 879-90. PMID 19536867 DOI: 10.1002/Jclp.20609  0.378
2009 Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophrenia Bulletin. 35: 894-908. PMID 19386578 DOI: 10.1093/Schbul/Sbp027  0.402
2009 Addington J, Tran L. Using the brief core schema scales with individuals at clinical high risk of psychosis. Behavioural and Cognitive Psychotherapy. 37: 227-31. PMID 19364422 DOI: 10.1017/S1352465809005116  0.336
2008 Addington J, Epstein I, Reynolds A, Furimsky I, Rudy L, Mancini B, McMillan S, Kirsopp D, Zipursky RB. Early detection of psychosis: finding those at clinical high risk. Early Intervention in Psychiatry. 2: 147-53. PMID 21352147 DOI: 10.1111/J.1751-7893.2008.00078.X  0.363
2008 Addington J, Addington D. Symptom remission in first episode patients. Schizophrenia Research. 106: 281-5. PMID 18926666 DOI: 10.1016/J.Schres.2008.09.014  0.347
2008 Addington J, Addington D. Outcome after discharge from an early psychosis program. Schizophrenia Research. 106: 363-6. PMID 18829260 DOI: 10.1016/J.Schres.2008.08.032  0.337
2008 Hawkins KA, Keefe RS, Christensen BK, Addington J, Woods SW, Callahan J, Zipursky RB, Perkins DO, Tohen M, Breier A, McGlashan TH. Neuropsychological course in the prodrome and first episode of psychosis: findings from the PRIME North America Double Blind Treatment Study. Schizophrenia Research. 105: 1-9. PMID 18774696 DOI: 10.1016/J.Schres.2008.07.008  0.39
2008 Mizrahi R, Addington J, Remington G, Kapur S. Attribution style as a factor in psychosis and symptom resolution Schizophrenia Research. 104: 220-227. PMID 18632256 DOI: 10.1016/J.Schres.2008.05.003  0.358
2008 Couture SM, Penn DL, Addington J, Woods SW, Perkins DO. Assessment of social judgments and complex mental states in the early phases of psychosis. Schizophrenia Research. 100: 237-41. PMID 18255273 DOI: 10.1016/J.Schres.2007.12.484  0.327
2008 Weiser M, Reichenberg A, Werbeloff N, Kravitz E, Halperin D, Lubin G, Shmushkevitch M, Yoffe R, Addington J, Davidson M. Self-report of family functioning and risk for psychotic disorders in male adolescents with behavioural disturbances. Acta Psychiatrica Scandinavica. 117: 225-31. PMID 18241305 DOI: 10.1111/J.1600-0447.2007.01143.X  0.377
2008 Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, Seidman LJ, Perkins D, Tsuang M, McGlashan T, Heinssen R. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Archives of General Psychiatry. 65: 28-37. PMID 18180426 DOI: 10.1001/Archgenpsychiatry.2007.3  0.435
2008 Addington J, Penn D, Woods SW, Addington D, Perkins DO. Facial affect recognition in individuals at clinical high risk for psychosis. The British Journal of Psychiatry : the Journal of Mental Science. 192: 67-8. PMID 18174514 DOI: 10.1192/Bjp.Bp.107.039784  0.4
2008 Addington J, Penn D, Woods SW, Addington D, Perkins DO. Social functioning in individuals at clinical high risk for psychosis. Schizophrenia Research. 99: 119-24. PMID 18023329 DOI: 10.1016/J.Schres.2007.10.001  0.376
2008 Mizrahi R, Addington J, Kapur S. ATTRIBUTION STYLE IS ASSOCIATED WITH SEVERITY OF PSYCHOTIC SYMPTOMS AND RECOVERY IN PRIMARY PSYCHOTIC DISORDERS Schizophrenia Research. 102: 215. DOI: 10.1016/S0920-9964(08)70649-2  0.315
2007 Hoffman RE, Woods SW, Hawkins KA, Pittman B, Tohen M, Preda A, Breier A, Glist J, Addington J, Perkins DO, McGlashan TH. Extracting spurious messages from noise and risk of schizophrenia-spectrum disorders in a prodromal population. The British Journal of Psychiatry : the Journal of Mental Science. 191: 355-6. PMID 17906248 DOI: 10.1192/Bjp.Bp.106.031195  0.362
2007 Addington J, Addington D. Social and cognitive functioning in psychosis. Schizophrenia Research. 99: 176-81. PMID 17681756 DOI: 10.1016/J.Schres.2007.07.004  0.32
2007 Dutta R, Greene T, Addington J, McKenzie K, Phillips M, Murray RM. Biological, life course, and cross-cultural studies all point toward the value of dimensional and developmental ratings in the classification of psychosis. Schizophrenia Bulletin. 33: 868-76. PMID 17562692 DOI: 10.1093/Schbul/Sbm059  0.377
2007 McGlashan TH, Addington J, Cannon T, Heinimaa M, McGorry P, O'Brien M, Penn D, Perkins D, Salokangas RK, Walsh B, Woods SW, Yung A. Recruitment and treatment practices for help-seeking "prodromal" patients. Schizophrenia Bulletin. 33: 715-26. PMID 17483100 DOI: 10.1093/Schbul/Sbm025  0.365
2007 McCleery A, Addington J, Addington D. Family assessment in early psychosis. Psychiatry Research. 152: 95-102. PMID 17449111 DOI: 10.1016/J.Psychres.2006.07.002  0.698
2007 Addington J, Addington D. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatrica Scandinavica. 115: 304-9. PMID 17355521 DOI: 10.1111/J.1600-0447.2006.00900.X  0.33
2007 Addington J, Cadenhead KS, Cannon TD, Cornblatt B, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Heinssen R. North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophrenia Bulletin. 33: 665-72. PMID 17255119 DOI: 10.1093/Schbul/Sbl075  0.408
2007 Addington J, McCleery A, Collins A, Addington D. Family Work in Early Psychosis Journal of Family Psychotherapy. 17: 137-153. DOI: 10.1300/J085V17N03_09  0.687
2006 Saeedi H, Addington J, Addington D. The association of insight with psychotic symptoms, depression, and cognition in early psychosis: a 3-year follow-up. Schizophrenia Research. 89: 123-8. PMID 17097272 DOI: 10.1016/J.Schres.2006.09.018  0.381
2006 McCleery A, Addington J, Addington D. Substance misuse and cognitive functioning in early psychosis: a 2 year follow-up. Schizophrenia Research. 88: 187-91. PMID 16942863 DOI: 10.1016/J.Schres.2006.06.040  0.703
2006 Addington J, Chaves A, Addington D. Diagnostic stability over one year in first-episode psychosis Schizophrenia Research. 86: 71-75. PMID 16750610 DOI: 10.1016/J.Schres.2006.04.018  0.388
2006 McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, Hawkins KA, Hoffman RE, Preda A, Epstein I, Addington D, Lindborg S, Trzaskoma Q, Tohen M, Breier A. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. The American Journal of Psychiatry. 163: 790-9. PMID 16648318 DOI: 10.1176/Ajp.2006.163.5.790  0.357
2006 Addington J, Saeedi H, Addington D. The course of cognitive functioning in first episode psychosis: changes over time and impact on outcome. Schizophrenia Research. 78: 35-43. PMID 15978781 DOI: 10.1016/J.Schres.2005.05.008  0.352
2006 Boydell K, Addington J, Goering P, McCay E, Krupa T, Gladstone B, Volpe T. 0469 YOUTH EXPERIENCING FIRST EPISODE PSYCHOSIS: A COMPREHENSIVE EXAMINATION OF PATHWAYS TO MENTAL HEALTH CARE Schizophrenia Research. 86: S124. DOI: 10.1016/S0920-9964(06)70372-3  0.302
2006 Hoffman RE, Woods S, Preda A, Tohen M, Breier A, Glist J, Addington J, Perkins DO, Hawkins K, McGlashan TH. Tc3A Excessive Top-Down Perceptual Processing And Reduced Real-World Investment Exhibited By Prodromal Patients Predict Subsequent Conversion To Schizophrenia Schizophrenia Research. 86. DOI: 10.1016/S0920-9964(06)70137-2  0.302
2006 Addington J, Haarmans M. Cognitive-Behavioral Therapy for Individuals Recovering from a First Episode of Psychosis Journal of Contemporary Psychotherapy. 36: 43-49. DOI: 10.1007/S10879-005-9005-6  0.368
2005 Addington J, Collins A, McCleery A, Addington D. The role of family work in early psychosis. Schizophrenia Research. 79: 77-83. PMID 16198240 DOI: 10.1016/J.Schres.2005.01.013  0.686
2005 Addington J, Gleeson J. Implementing cognitive-behavioural therapy for first-episode psychosis. The British Journal of Psychiatry. Supplement. 48: s72-6. PMID 16055812 DOI: 10.1192/Bjp.187.48.S72  0.348
2005 Addington J. Cannabis use increases the risk of young people developing psychotic symptoms, particularly if already predisposed. Evidence-Based Mental Health. 8: 87. PMID 16043629 DOI: 10.1136/Ebmh.8.3.87  0.391
2005 Addington J, Addington D. Clinical trials during the prodromal stage of schizophrenia. The American Journal of Psychiatry. 162: 1387. PMID 15994732 DOI: 10.1176/Appi.Ajp.162.7.1387  0.315
2005 Addington J, McCleery A, Addington D. Three-year outcome of family work in an early psychosis program. Schizophrenia Research. 79: 107-16. PMID 15907375 DOI: 10.1016/J.Schres.2005.03.019  0.7
2005 Pencer A, Addington J, Addington D. Outcome of a first episode of psychosis in adolescence: a 2-year follow-up. Psychiatry Research. 133: 35-43. PMID 15698675 DOI: 10.1016/J.Psychres.2004.10.004  0.795
2004 Addington J. The diagnosis and assessment of individuals prodromal for schizophrenic psychosis. Cns Spectrums. 9: 588-94. PMID 15273651 DOI: 10.1017/S1092852900002753  0.393
2004 Hawkins KA, McGlashan TH, Quinlan D, Miller TJ, Perkins DO, Zipursky RB, Addington J, Woods SW. Factorial structure of the Scale of Prodromal Symptoms. Schizophrenia Research. 68: 339-47. PMID 15099615 DOI: 10.1016/S0920-9964(03)00053-7  0.352
2004 Mastrigt SV, Addington J, Addington D. Substance misuse at presentation to an early psychosis program. Social Psychiatry and Psychiatric Epidemiology. 39: 69-72. PMID 15022049 DOI: 10.1007/S00127-004-0713-0  0.369
2004 Mintz AR, Addington J, Addington D. Insight in early psychosis: a 1-year follow-up. Schizophrenia Research. 67: 213-7. PMID 14984880 DOI: 10.1016/S0920-9964(03)00047-1  0.37
2004 Hawkins KA, Addington J, Keefe RS, Christensen B, Perkins DO, Zipurksy R, Woods SW, Miller TJ, Marquez E, Breier A, McGlashan TH. Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophrenia Research. 67: 115-22. PMID 14984870 DOI: 10.1016/J.Schres.2003.08.007  0.363
2004 Addington J, Van Mastrigt S, Addington D. Duration of untreated psychosis: impact on 2-year outcome. Psychological Medicine. 34: 277-84. PMID 14982133 DOI: 10.1017/S0033291703001156  0.322
2004 Addington J, Williams J, Young J, Addington D. Suicidal behaviour in early psychosis. Acta Psychiatrica Scandinavica. 109: 116-20. PMID 14725592 DOI: 10.1046/J.0001-690X.2003.00232.X  0.335
2004 Addington J, Young J, Addington D. Social outcome in early psychosis. Psychological Medicine. 33: 1119-24. PMID 12946096 DOI: 10.1017/S0033291703007815  0.32
2004 Addington J, van Mastrigt S, Addington D. Patterns of premorbid functioning in first-episode psychosis: initial presentation. Schizophrenia Research. 62: 23-30. PMID 12765739 DOI: 10.1016/S0920-9964(02)00408-5  0.362
2003 Woods SW, Breier A, Zipursky RB, Perkins DO, Addington J, Miller TJ, Hawkins KA, Marquez E, Lindborg SR, Tohen M, McGlashan TH. Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biological Psychiatry. 54: 453-64. PMID 12915290 DOI: 10.1016/S0006-3223(03)00321-4  0.309
2003 Quillams L, Addington J. Insight, knowledge, and beliefs about illness in first-episode psychosis. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 48: 350. PMID 12866346 DOI: 10.1177/070674370304800516  0.307
2003 Addington J, Brooks BL, Addington D. Cognitive functioning in first episode psychosis: initial presentation. Schizophrenia Research. 62: 59-64. PMID 12765744 DOI: 10.1016/S0920-9964(02)00340-7  0.358
2003 Addington J, Leriger E, Addington D. Symptom outcome 1 year after admission to an early psychosis program. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 48: 204-7. PMID 12728745 DOI: 10.1177/070674370304800309  0.334
2003 Miller TJ, Zipursky RB, Perkins D, Addington J, Woods SW, Hawkins KA, Hoffman R, Preda A, Epstein I, Addington D, Lindborg S, Marquez E, Tohen M, Breier A, McGlashan TH. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample. Schizophrenia Research. 61: 19-30. PMID 12648732 DOI: 10.1016/S0920-9964(02)00440-1  0.44
2003 McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller TJ, Woods SW, Hawkins KA, Hoffman R, Lindborg S, Tohen M, Breier A. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophrenia Research. 61: 7-18. PMID 12648731 DOI: 10.1016/S0920-9964(02)00439-5  0.362
2003 Pencer A, Addington J. Substance use and cognition in early psychosis. Journal of Psychiatry & Neuroscience : Jpn. 28: 48-54. PMID 12587850  0.779
2003 Addington J, Van Mastrigt S, Hutchinson J, Addington D. Pathways to care: help seeking behaviour in first episode psychosis. Acta Psychiatrica Scandinavica. 106: 358-64. PMID 12366470 DOI: 10.1034/J.1600-0447.2002.02004.X  0.331
2003 McGlashan TH, Zipursky RB, Perkins DO, Addington J, Woods SW, Miller TJ, Lindborg S, Marquez E, Hawkins K, Hoffman RE, Tohen M, Breier A. Olanzapine versus placebo treatment of the schizophrenia prodrome: One year results Schizophrenia Research. 60: 295. DOI: 10.1016/S0920-9964(03)80497-8  0.317
2002 Addington D, Addington J, Patten S, Remington G, Moamai J, Labelle A, Beauclair L. Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia. Journal of Clinical Psychopharmacology. 22: 20-5. PMID 11799338 DOI: 10.1097/00004714-200202000-00004  0.34
2002 Addington J, Addington D. Impact of an early psychosis program on substance use. Psychiatric Rehabilitation Journal. 25: 60-7. PMID 11529454 DOI: 10.1037/H0095049  0.334
2002 Addington J, Van Mastrigt S, Addington D. Duration of untreated psychosis: impact on 2-year outcome Acta Psychiatrica Scandinavica. 106: 69-106. DOI: 10.1034/J.1600-0447.106.S413.1_14.X  0.343
2002 Addington J, Addington D. Diagnoses at the first psychotic episode and cognitive functioning Acta Psychiatrica Scandinavica. 106: 69-106. DOI: 10.1034/J.1600-0447.106.S413.1_131.X  0.402
2002 Mintz A, Addington J, Addington D. Insight in early psychosis: a 1 year follow-up Acta Psychiatrica Scandinavica. 106: 69-106. DOI: 10.1034/J.1600-0447.106.S413.1_130.X  0.372
2002 Pencer A, Addington J, Hogg L, Addington D. Longitudinal outcome of first episode psychosis in adolescence Acta Psychiatrica Scandinavica. 106: 69-106. DOI: 10.1034/J.1600-0447.106.S413.1_129.X  0.792
2001 Grant C, Addington J, Addington D, Konnert C. Social functioning in first- and multiepisode schizophrenia Canadian Journal of Psychiatry. 46: 746-749. PMID 11692978 DOI: 10.1177/070674370104600808  0.329
2001 Martens L, Addington J. The psychological well-being of family members of individuals with schizophrenia Social Psychiatry and Psychiatric Epidemiology. 36: 128-133. PMID 11465784 DOI: 10.1007/S001270050301  0.338
2001 Addington J, Addington D, Gasbarre L. Neurocognitive and social functioning in schizophrenia and other diagnoses. Schizophrenia Research. 48: 367-8. PMID 11295389 DOI: 10.1016/S0920-9964(00)00103-1  0.314
2001 Addington J, Addington D, Jones B, Ko T. Family intervention in an early psychosis program Psychiatric Rehabilitation Skills. 5: 272-286. DOI: 10.1080/15487760108415433  0.335
2000 Addington J, Addington D. Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study. Schizophrenia Research. 44: 47-56. PMID 10867311 DOI: 10.1016/S0920-9964(99)00160-7  0.317
1999 Addington D, Addington J, Robinson G. Attributional style and depression in schizophrenia. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 44: 697-700. PMID 10500872 DOI: 10.1177/070674379904400708  0.324
1999 El-Guebaly N, Hodgins DC, Armstrong S, Addington J. Methodological and clinical challenges in evaluating treatment outcome of substance-related disorders and comorbidity Canadian Journal of Psychiatry. 44: 264-270. PMID 10225128 DOI: 10.1177/070674379904400307  0.302
1999 Addington J, Addington D. Neurocognitive and social functioning in schizophrenia. Schizophrenia Bulletin. 25: 173-82. PMID 10098920 DOI: 10.1093/Oxfordjournals.Schbul.A033363  0.309
1999 Addington J, el-Guebaly N, Duchak V, Hodgins D. Using measures of readiness to change in individuals with schizophrenia. The American Journal of Drug and Alcohol Abuse. 25: 151-61. PMID 10078983 DOI: 10.1081/Ada-100101851  0.351
1999 Addington J, Addington D. Visual attention and symptoms in schizophrenia: a 1-year follow-up. Schizophrenia Research. 34: 95-9. PMID 9824881 DOI: 10.1016/S0920-9964(98)00074-7  0.325
1999 Addington J, el-Guebaly N. Group treatment for substance abuse in schizophrenia. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 43: 843-5. PMID 9806092 DOI: 10.1177/070674379804300810  0.348
1998 Addington J, McCleary L, Munroe-Blum H. Relationship between cognitive and social dysfunction in schizophrenia. Schizophrenia Research. 34: 59-66. PMID 9824877 DOI: 10.1016/S0920-9964(98)00079-6  0.307
1998 Addington J, Addington D. Facial affect recognition and information processing in schizophrenia and bipolar disorder. Schizophrenia Research. 32: 171-81. PMID 9720122 DOI: 10.1016/S0920-9964(98)00042-5  0.307
1998 Addington J. Group treatment for smoking cessation among persons with schizophrenia. Psychiatric Services (Washington, D.C.). 49: 925-8. PMID 9661227 DOI: 10.1176/Ps.49.7.925  0.308
1998 Addington J, El-Guebaly N, Campbell W, Hodgins DC, Addington D. Smoking cessation treatment for patients with schizophrenia American Journal of Psychiatry. 155: 974-976. PMID 9659869 DOI: 10.1176/Ajp.155.7.974  0.308
1998 Addington J, Addington D. Neurocognitive functioning in schizophrenia: a trial of risperidone versus haloperidol. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 42: 983. PMID 9429073 DOI: 10.1177/070674379704200919  0.309
1998 Addington J, Duchak V. Reasons for substance use in schizophrenia. Acta Psychiatrica Scandinavica. 96: 329-33. PMID 9395149 DOI: 10.1111/J.1600-0447.1997.Tb09925.X  0.353
1998 Addington J, Addington D. Effect of substance misuse in early psychosis British Journal of Psychiatry. 172: 134-136. DOI: 10.1192/S0007125000297791  0.386
1998 Addington D, Addington J, Patten S. Depression in people with first-episode schizophrenia British Journal of Psychiatry. 172: 90-92. DOI: 10.1192/S0007125000297729  0.359
1997 Addington J, Addington D. Attentional vulnerability indicators in schizophrenia and bipolar disorder. Schizophrenia Research. 23: 197-204. PMID 9075297 DOI: 10.1016/S0920-9964(96)00105-3  0.325
1996 Addington D, Addington J, Atkinson M. A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale. Schizophrenia Research. 19: 205-12. PMID 8789919 DOI: 10.1016/0920-9964(95)00070-4  0.332
1996 Addington D, Addington J, Patten S. Course, correlates and predictors of depression in schizophrenia Schizophrenia Research. 18: 117. DOI: 10.1016/0920-9964(96)85399-0  0.325
1995 Addington J, Addington D. Cognitive and social functioning in schizophrenia Schizophrenia Research. 15: 107. DOI: 10.1016/0920-9964(95)95328-7  0.326
1995 Addington D, Addington J, Atkinson M. Factor analysis of depression scales in schizophrenia Schizophrenia Research. 15: 5. DOI: 10.1016/0920-9964(95)95025-5  0.305
1994 Addington D, Addington J, Maticka-Tyndale E. Specificity of the Calgary Depression Scale for schizophrenics Schizophrenia Research. 11: 239-244. PMID 8193062 DOI: 10.1016/0920-9964(94)90017-5  0.319
1993 ADDINGTON D, ADDINGTON J, MATICKA-TYNDALE E. Rating Depression in Schizophrenia The Journal of Nervous and Mental Disease. 181: 561-565. DOI: 10.1097/00005053-199309000-00006  0.313
1993 Addington J, Addington D. Visual attention and positive and negative symptoms of schizophrenia Schizophrenia Research. 9: 171. DOI: 10.1016/0920-9964(93)90325-D  0.3
1991 Addington J, Addington D, Maticka-Tyndale E. Cognitive functioning and positive and negative symptoms in schizophrenia Schizophrenia Research. 5: 123-134. PMID 1931805 DOI: 10.1016/0920-9964(91)90039-T  0.353
1991 Addington J, Addington D. Positive and negative symptoms of schizophrenia. Their course and relationship over time. Schizophrenia Research. 5: 51-9. PMID 1854677 DOI: 10.1016/0920-9964(91)90053-T  0.333
1991 Addington J, Addington D. Gender differences in cognitive functioning and symptoms in schizophrenics Schizophrenia Research. 4: 273. DOI: 10.1016/0920-9964(91)90135-E  0.324
Show low-probability matches.